Verily Pre

Verily Health: AI-Native Precision Health Platform — Company Profile

AI-native multimodal health data platform powering chronic care management, wastewater epidemiology, clinical trial operations, and real-world evidence generation

A structured profile of Verily Health Inc., the AI-native precision health platform company that became formally independent from Alphabet in March 2026, covering its Verily Pre platform architecture, product portfolio (Lightpath, Sightline, Viewpoint, Verily Me), validated clinical partnerships, funding history, and known limitations — for health system administrators, CIOs, clinical researchers, and procurement teams evaluating the company's capabilities and strategic position.

Precision health, chronic care, epidemiology, clinical trials, oncologyBy Editorial Team

Product Facts

Product Name: Verily Pre
Clinical Specialty: Precision health, chronic care, epidemiology, clinical trials, oncology
Primary Use Case: AI-native multimodal health data platform powering chronic care management, wastewater epidemiology, clinical trial operations, and real-world evidence generation
Regulatory Clearance: No FDA clearance or SaMD status confirmed for Verily Pre or Lightpath; Dexcom G7 partnership FDA-approved 2022 (US)
Evidence Tier: Retrospective study (UCHealth/CU Anschutz AML models: 95% accuracy, 30x faster extraction); NIH All of Us deployment (21,500+ researchers)
EHR Integrations: FHIR-native; Epic and Oracle Health integrations not confirmed in available sources
Funding / Company Stage: Independent corporation (subsidiary of Alphabet until March 2026); $300M round closed March 2026, led by Series X Capital; Alphabet significant minority investor
Profile Last Verified: 2026-06-10

This profile presents structured facts and is not a recommendation or endorsement. Profile information was last verified on the date shown above. The healthcare AI landscape changes rapidly — always verify current regulatory status with the issuing authority.

Discussion

Comments do not constitute clinical guidance. You may share deployment experience, flag outdated profile information, or note discrepancies with current vendor information. The 2026-06-10 field indicates when this profile was last reviewed.

Comments

Join the discussion with an anonymous comment.

Loading comments...